Cold plasma efficacy in grain mycotoxin reduction
Recent peer-reviewed findings on the effectiveness of cold plasma for treating mycotoxin contamination in stored grain.
Read more →NanoGuard Technologies develops patented cold plasma solutions that replace harsh, residue-heavy treatment methods with a modern, scalable platform — engineered for real-world industrial use.
NanoGuard's cold plasma platform offers industries a controllable, low-residue alternative to legacy treatment methods such as toxic fumigants, harsh chemistries, and high-heat processes. Our technology is designed to scale — adaptable across applications where safety, cleanliness, and operational efficiency matter.
Cold plasma is an ionized gas generated at near-ambient temperatures. It produces reactive species capable of decontaminating surfaces, materials, and flowing media — without the heat, residues, or toxicity of conventional chemical or thermal approaches.
NanoGuard's proprietary approach is built around indirect, scalable treatment — a design philosophy that prioritizes throughput, consistency, and operational integration. The result: a treatment method that fits modern industrial workflows instead of disrupting them.
Learn About the TechnologyNanoGuard's IP portfolio anchors the commercial defensibility of our technology and unlocks application across multiple industries.
Stable, controllable cold plasma production engineered for industrial-scale throughput and reliability.
Treatment architecture that delivers plasma effects safely and uniformly across target media.
System-level design enabling deployment within existing industrial workflows and facility footprints.
Tunable parameters that adapt the platform to multiple industry use cases without redesign.
Many industries still depend on treatment methods that are toxic to handle, leave residues behind, demand long cycle times, or carry growing regulatory pressure. NanoGuard offers an alternative built for where industry is heading.
Low- to no-residue treatment by design.
Reduced reliance on hazardous chemistry.
Engineered for efficient, integrated cycles.
A platform technology, not a one-off device.
NanoGuard's cold plasma technology has commercial relevance across sectors where treatment quality, safety, and throughput drive value.
Mycotoxin reduction and microbial control without harsh fumigation chemistry.
Explore →Surface treatment supporting cleaner seed inputs and improved germination performance.
Explore →Reactive-species generation that reduces dependence on chlorinated chemistry.
Explore →Whether you're evaluating a specific application, exploring a partnership, or simply want to understand how cold plasma could fit your operations — our team is ready to talk.
Recent peer-reviewed findings on the effectiveness of cold plasma for treating mycotoxin contamination in stored grain.
Read more →Tightening regulation, ESG pressure, and worker safety are reshaping the economics of conventional treatment.
Read more →An update on commercial development priorities and partnership pipeline across grain, water, and cultivation.
Read more →